116 related articles for article (PubMed ID: 38523383)
1. The role of proangiogenic cytokines in predicting sepsis in febrile neutropenic children with cancer.
Çakmakcı S; Sarı N; Sönmez Ç; İlhan İE
Turk J Pediatr; 2024; 66(1):90-98. PubMed ID: 38523383
[TBL] [Abstract][Full Text] [Related]
2. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.
Luz Fiusa MM; Costa-Lima C; de Souza GR; Vigorito AC; Penteado Aranha FJ; Lorand-Metze I; Annichino-Bizzacchi JM; de Souza CA; De Paula EV
Crit Care; 2013 Aug; 17(4):R169. PubMed ID: 23915833
[TBL] [Abstract][Full Text] [Related]
3. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
[TBL] [Abstract][Full Text] [Related]
4. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
5. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
[TBL] [Abstract][Full Text] [Related]
6. Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia.
Alves BE; Montalvao SA; Aranha FJ; Siegl TF; Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; De Paula EV
BMC Infect Dis; 2010 May; 10():143. PubMed ID: 20509945
[TBL] [Abstract][Full Text] [Related]
7. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study.
Alves BE; Montalvao SA; Aranha FJ; Lorand-Metze I; De Souza CA; Annichino-Bizzacchi JM; De Paula EV
J Transl Med; 2011 Mar; 9():23. PubMed ID: 21371321
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Mimaroğlu E; Çıtak EÇ; Kuyucu N; Eskendari G
Turk J Pediatr; 2017; 59(4):418-425. PubMed ID: 29624222
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
10. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
11. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer.
Tapia LI; Olivares M; Torres JP; De la Maza V; Valenzuela R; Contardo V; Tordecilla J; Álvarez AM; Varas M; Zubieta M; Salgado C; Venegas M; Gutiérrez V; Claverie X; Villarroel M; Santolaya ME
Cytokine; 2021 Dec; 148():155619. PubMed ID: 34134910
[TBL] [Abstract][Full Text] [Related]
13. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.
Kitanovski L; Jazbec J; Hojker S; Derganc M
Support Care Cancer; 2014 Jan; 22(1):269-77. PubMed ID: 24057110
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
Srinivasan A; Kumar N; Scott JX
Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
[TBL] [Abstract][Full Text] [Related]
17. Simple predictors of the re- occurrence of severe febrile neutropenia episode: a single-center retrospective cohort study in pediatric patients with malignant diseases.
Šegulja S; Ružić A; Dujmić D; Baždarić K; Roganović J
Croat Med J; 2019 Feb; 60(1):20-25. PubMed ID: 30825274
[TBL] [Abstract][Full Text] [Related]
18. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
Intke C; Korpelainen S; Lappalainen M; Vänskä M; Hämäläinen S; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Clin Exp Med; 2022 Feb; 22(1):83-93. PubMed ID: 34255216
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
20. The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
Cerasi S; Leardini D; Lisanti N; Belotti T; Pierantoni L; Zama D; Lanari M; Prete A; Masetti R
Sci Rep; 2023 Apr; 13(1):6464. PubMed ID: 37081067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
